查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386384

DNA 疫苗市场报告：2030 年趋势、预测与竞争分析

DNA Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

DNA疫苗趋势与预测

预计到 2030 年，全球 DNA 疫苗市场将达到 8 亿美元，2024 年至 2030 年复合年增长率为 6.5%。该市场的主要驱动力是人类和动物癌症和感染疾病发病率的增加，以及对透过基因工程 DNA 细胞直接产生抗原的疫苗的需求不断增长。仅此而已。全球DNA疫苗市场前景广阔，为兽医院和兽医诊所带来市场机会。

DNA 疫苗市场洞察

Lucintel 预测 Oncept 将仍然是最大的细分市场，因为它在避免动物黑色素瘤扩散方面具有重要用途。

由于兽药领域主要企业的存在和完善的组织结构，预计北美在预测期内将出现最高的成长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去五年发生了哪些併购事件，对产业产生了哪些影响？

目录

第一章执行摘要

第二章全球DNA疫苗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球DNA疫苗市场趋势（2018-2023）与预测（2024-2030）
  • 按产品类型分類的全球 DNA 疫苗市场
    • 概念
    • 西尼罗河创新者
    • Apex-IHN
  • 全球 DNA 疫苗市场（按类型）
    • 治疗性疫苗
    • 预防性疫苗
  • 全球 DNA 疫苗市场（依最终用途）
    • 动物诊所
    • 动物医院

第四章 2018-2030年区域市场趋势及预测分析

  • 全球DNA疫苗市场区域分布
  • 北美DNA疫苗市场
  • 欧洲DNA疫苗市场
  • 亚太地区DNA疫苗市场
  • 其他地区DNA疫苗市场

第五章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按产品类型分類的全球 DNA 疫苗市场成长机会
    • 按类型分類的全球 DNA 疫苗市场成长机会
    • 全球 DNA 疫苗市场成长机会（依最终用途）
    • 全球 DNA 疫苗市场成长机会（按地区）
  • 全球DNA疫苗市场新趋势
  • 战略分析
    • 新产品开发
    • 全球DNA疫苗市场产能扩张
    • 全球DNA疫苗市场的合併、收购和合资企业
    • 认证和许可

第七章主要企业概况

  • Geovax Labs
  • Viatris
  • Inovio Pharmaceuticals
  • Zydus Cadila
  • Geneone Life Science
  • Eli-Lilly
  • Zoetis
  • Takara Holdings
  • Boehringer Ingelheim
  • Genexine
简介目录

DNA Vaccine Trends and Forecast

The future of the global DNA vaccine market looks promising with opportunities in the veterinary clinic and veterinary hospital markets. The global DNA vaccine market is expected to reach an estimated $0.8 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are rising occurrence of cases of cancer and infectious diseases in human and animals and growing demand for these vaccines among genetically engineered DNA cells to directly produce an antigen.

A more than 150-page report is developed to help in your business decisions.

DNA Vaccine by Segment

The study includes a forecast for the global DNA vaccine by product type, type, end use, and region.

DNA Vaccine Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Oncept
  • West Nile-Innovator
  • Apex-IHN

DNA Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Therapeutic Vaccines
  • Prophylactic Vaccines

DNA Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Veterinary Clinics
  • Veterinary Hospitals

DNA Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of DNA Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies DNA vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the DNA vaccine companies profiled in this report include-

  • Geovax Labs
  • Viatris
  • Inovio Pharmaceuticals
  • Zydus Cadila
  • Geneone Life Science
  • Eli-Lilly
  • Zoetis
  • Takara Holdings
  • Boehringer Ingelheim
  • Genexine

DNA Vaccine Market Insights

Lucintel forecasts that oncept will remain the largest segment due to its significant usage to avoid prevalence of canine melanoma cancer in animals.

North America is expected to witness highest growth over the forecast period due to the presence of major key players and existence of well-established veterinary organizational structures in the region.

Features of the Global DNA Vaccine Market

Market Size Estimates: DNA vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: DNA vaccine market size by product type, type, end use, and region in terms of value ($B).

Regional Analysis: DNA vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, types, end uses, and regions for the DNA vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the DNA vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the DNA vaccine market size?

Answer: The global DNA vaccine market is expected to reach an estimated $0.8 billion by 2030.

Q.2 What is the growth forecast for DNA vaccine market?

Answer: The global DNA vaccine market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the DNA vaccine market?

Answer: The major drivers for this market are rising occurrence of cases of cancer and infectious diseases in human and animals and growing demand for these vaccines among genetically engineered DNA cells to directly produce an antigen.

Q4. What are the major segments for DNA vaccine market?

Answer: The future of the DNA vaccine market looks promising with opportunities in the therapeutic and prophylactic markets.

Q5. Who are the key DNA vaccine market companies?

Answer: Some of the key DNA vaccine companies are as follows:

  • Geovax Labs
  • Viatris
  • Inovio Pharmaceuticals
  • Zydus Cadila
  • Geneone Life Science
  • Eli-Lilly
  • Zoetis
  • Takara Holdings
  • Boehringer Ingelheim
  • Genexine

Q6. Which DNA vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that oncept will remain the largest segment due to its significant usage to avoid prevalence of canine melanoma cancer in animals.

Q7. In DNA vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to the presence of major key players and existence of well-established veterinary organizational structures in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the DNA vaccine market by product type (oncept, west nile-innovator, and apex-IHN), type (therapeutic vaccines and prophylactic vaccines), end use (veterinary clinics and veterinary hospitals), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global DNA Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global DNA Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global DNA Vaccine Market by Product Type
    • 3.3.1: Oncept
    • 3.3.2: West Nile-Innovator
    • 3.3.3: Apex-IHN
  • 3.4: Global DNA Vaccine Market by Type
    • 3.4.1: Therapeutic Vaccines
    • 3.4.2: Prophylactic Vaccines
  • 3.5: Global DNA Vaccine Market by End Use
    • 3.5.1: Veterinary Clinics
    • 3.5.2: Veterinary Hospitals

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global DNA Vaccine Market by Region
  • 4.2: North American DNA Vaccine Market
    • 4.2.2: North American DNA Vaccine Market by Type: Therapeutic Vaccines and Prophylactic Vaccines
  • 4.3: European DNA Vaccine Market
    • 4.3.1: European DNA Vaccine Market by Product Type: Oncept, West Nile-Innovator, and Apex-IHN
    • 4.3.2: European DNA Vaccine Market by Type: Therapeutic Vaccines and Prophylactic Vaccines
  • 4.4: APAC DNA Vaccine Market
    • 4.4.1: APAC DNA Vaccine Market by Product Type: Oncept, West Nile-Innovator, and Apex-IHN
    • 4.4.2: APAC DNA Vaccine Market by Type: Therapeutic Vaccines and Prophylactic Vaccines
  • 4.5: ROW DNA Vaccine Market
    • 4.5.1: ROW DNA Vaccine Market by Product Type: Oncept, West Nile-Innovator, and Apex-IHN
    • 4.5.2: ROW DNA Vaccine Market by Type: Therapeutic Vaccines and Prophylactic Vaccines

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global DNA Vaccine Market by Product Type
    • 6.1.2: Growth Opportunities for the Global DNA Vaccine Market by Type
    • 6.1.3: Growth Opportunities for the Global DNA Vaccine Market by End Use
    • 6.1.4: Growth Opportunities for the Global DNA Vaccine Market by Region
  • 6.2: Emerging Trends in the Global DNA Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global DNA Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global DNA Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Geovax Labs
  • 7.2: Viatris
  • 7.3: Inovio Pharmaceuticals
  • 7.4: Zydus Cadila
  • 7.5: Geneone Life Science
  • 7.6: Eli-Lilly
  • 7.7: Zoetis
  • 7.8: Takara Holdings
  • 7.9: Boehringer Ingelheim
  • 7.10: Genexine